Hormone therapy for prostate cancer Doctors Abroad — Page 2

Associate Professor Nail Paksoy is a European-certified oncologist who focuses on advanced medical treatments for prostate and uro-oncological cancers at Medipol Hospital.

• ESMO Board Certified in Medical Oncology, recognised by the European Society for Medical Oncology
• Active subinvestigator in international clinical trials for targeted cancer therapies
• Published research on PSMA-based tumour burden and outcomes in prostate cancer
• Specialised fellowship training at the Istanbul University Oncology Institute
• Expertise in administering complex hormone and immunotherapy protocols

Associate Professor Abdullah Sakin is a former Head of Medical Oncology who specialised in complex cancer care at major Turkish university hospitals.

• Served as the Education Officer at the Prof Dr Cemil Tascioglu City Hospital, training the next generation of oncologists
• Led the Department of Medical Oncology at Yuzuncu Yil University Faculty of Medicine
• Board-certified medical oncologist with extensive training from Okmeydani Training and Research Hospital
• Focuses on evidence-based medication protocols for hormone-dependent malignancies

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.

• Expert in functional rehabilitation for patients recovering from oral cancer.
• Active researcher with multiple publications in various medical journals.
• Works at an NABH-accredited center that treats over 75,000 patients yearly.
• Treats complex conditions including tongue, thyroid, and tonsil cancers.

Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.

• Participated as a lead investigator in more than 200 clinical trials.
• Serves as a professor for DNB Superspecialty Surgical Oncology.
• Expert in complex procedures including mastectomy and thoracic resections.
• Founder of Curie Manavata Cancer Centre, a major regional treatment hub.

Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.

• Specializes in minimally invasive procedures, including laparoscopy and thoracoscopy.
• Performs robotic cancer surgeries and advanced endoscopic procedures.
• Served as a former assistant professor at the State Cancer Institute.
• Acts as a co-principal investigator for original clinical research projects.
• Treats complex esophageal, stomach, colon, and rectal cancers.

Dr Shaunak Valame is a dedicated medical oncologist at HCG Manavata Cancer Centre with extensive training from Indraprastha Apollo Hospital in New Delhi.

• Specialises in the molecular basis of cancer and targeted hormone therapies
• Presented research at the American Society of Clinical Oncology symposium in San Francisco
• Completed specialist DNB training in Medical Oncology at the prestigious Indraprastha Apollo Hospital
• Expertise in managing complex prostate cases using evidence-based medical protocols
• Served as a lecturer for the International Winter School of Oncology programme

Dr Shruti Kate serves as the Head of Department at HCG Manavata Cancer Centre following a prestigious clinical background at Tata Memorial Hospital.

• Specialises in genitourinary cancers including advanced prostate cases
• Uses metronomic therapy and immunotherapy to manage aggressive malignancies
• Held a senior consultant role at Mumbai's Tata Memorial Hospital
• Recognised with a global travel award by the International Association for the Study of Lung Cancer
• Member of the American Society of Clinical Oncology and ESMO

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

Dr Sridhar P.S. is a specialist radiation oncologist at HCG Manavata Cancer Centre with double board certifications in India.

• Holds a Diplomate of National Board in radiotherapy and a Doctor of Medicine from Banaras Hindu University
• Active member of the Association of Radiation Oncology of India
• Part of the Society for Neuro-Oncology focus group
• Member of the Indian Association of Hyperthermia Oncology
• Specialises in using targeted radiotherapy protocols for oncology patients